SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-675916
Filing Date
2016-08-09
Accepted
2016-08-09 06:08:03
Documents
3
Period of Report
2016-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d240007d8k.htm 8-K 14535
2 EX-99.1 d240007dex991.htm EX-99.1 358574
3 GRAPHIC g2400072.jpg GRAPHIC 11447
  Complete submission text file 0001193125-16-675916.txt   390255
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 161815943
SIC: 2834 Pharmaceutical Preparations